RFX1-CCDC107 Fusion FISH Probe
The RFX1-CCDC107 Fusion FISH Probe is used to confirm a fusion of the RFX1 and CCDC107 genes. The fusion of the RFX1 and CCDC107 genes has been associated with Ovarian Serous Cystadenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| RFX1-CCDC107-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-RERE | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-REOR | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-REGO | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-REGR | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-OROR | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GORE | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GROR | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| RFX1-CCDC107-20-AQAQ | 20 (40 μL) | 200 μL |
|
RFX1 Gene Summary
This gene encodes a member of the regulatory factor X (RFX) family of transcription factors, which are characterized by a winged-helix DNA-binding domain. The encoded transcription factor contains an N-terminal activation domain and a C-terminal repression domain, and may activate or repress target gene expression depending on cellular context. This transcription factor has been shown to regulate a wide variety of genes involved in immunity and cancer, including the MHC class II genes and genes that may be involved in cancer progression. This gene exhibits altered expression in glioblastoma and the autoimmune disease systemic lupus erythematosis (SLE). [provided by RefSeq, Jul 2016]
Gene Name: Regulatory Factor X1
Chromosome: CHR19: 14072341 -14117134
Locus: 19p13.12
CCDC107 Gene Summary
This gene encodes a membrane protein which contains a coiled-coil domain in the central region. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2013]
Gene Name: Coiled-coil Domain Containing 107
Chromosome: CHR9: 35658286 -35661500
Locus: 9p13.3
Gene Diseases
The RFX1 CCDC107 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Ovarian Serous Cystadenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|